J Siracký

591 total citations
43 papers, 474 citations indexed

About

J Siracký is a scholar working on Molecular Biology, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, J Siracký has authored 43 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Obstetrics and Gynecology and 8 papers in Oncology. Recurrent topics in J Siracký's work include Endometrial and Cervical Cancer Treatments (12 papers), Ovarian cancer diagnosis and treatment (5 papers) and Reproductive Biology and Fertility (3 papers). J Siracký is often cited by papers focused on Endometrial and Cervical Cancer Treatments (12 papers), Ovarian cancer diagnosis and treatment (5 papers) and Reproductive Biology and Fertility (3 papers). J Siracký collaborates with scholars based in Slovakia, United Kingdom and Czechia. J Siracký's co-authors include Kenneth R. Harrap, E Siracká, Anne P. Wilson, Lloyd R. Kèlland, G Abel, Láśzló Révész, M Blaŝko, Mark Jones, Pamela J. Schreiner and G Delides and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J Siracký

39 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Siracký Slovakia 11 220 179 109 66 51 43 474
M. Koukourakis Greece 12 227 1.0× 284 1.6× 125 1.1× 96 1.5× 125 2.5× 28 563
Gustavo Ismael Belgium 6 296 1.3× 128 0.7× 83 0.8× 150 2.3× 55 1.1× 10 495
Arnold Mittelman United States 15 310 1.4× 192 1.1× 218 2.0× 23 0.3× 103 2.0× 36 729
Steven W. Remmenga United States 13 157 0.7× 347 1.9× 83 0.8× 39 0.6× 83 1.6× 20 720
Jane C. Wright United States 14 215 1.0× 144 0.8× 83 0.8× 40 0.6× 93 1.8× 42 490
Ainura Kyshtoobayeva United States 13 420 1.9× 441 2.5× 192 1.8× 169 2.6× 95 1.9× 18 859
Lidija Beketić-Orešković Croatia 13 276 1.3× 288 1.6× 102 0.9× 20 0.3× 36 0.7× 37 591
F G Hay United Kingdom 5 166 0.8× 200 1.1× 54 0.5× 31 0.5× 22 0.4× 9 375
Yukihisa Minagawa Japan 16 198 0.9× 188 1.1× 48 0.4× 22 0.3× 50 1.0× 35 572
Y Tenjin Japan 11 117 0.5× 184 1.0× 86 0.8× 15 0.2× 131 2.6× 38 488

Countries citing papers authored by J Siracký

Since Specialization
Citations

This map shows the geographic impact of J Siracký's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Siracký with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Siracký more than expected).

Fields of papers citing papers by J Siracký

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Siracký. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Siracký. The network helps show where J Siracký may publish in the future.

Co-authorship network of co-authors of J Siracký

This figure shows the co-authorship network connecting the top 25 collaborators of J Siracký. A scholar is included among the top collaborators of J Siracký based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Siracký. J Siracký is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borovanský, J, M Blaŝko, J Siracký, et al.. (1997). Cytotoxic interactions of Zn2+ in vitro: melanoma cells are more susceptible than melanocytes. Melanoma Research. 7(6). 449–453. 11 indexed citations
2.
Jones, Mark, J Siracký, LR Kelland, & KR Harrap. (1993). Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts. British Journal of Cancer. 67(1). 24–29. 21 indexed citations
3.
4.
Kysela, Boris, et al.. (1990). Flow cytometry (FCM) analysis of endometrial hyperplasia and carcinoma.. PubMed. 37(5). 489–95. 4 indexed citations
5.
Kèlland, Lloyd R., et al.. (1989). Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes. British Journal of Cancer. 59(4). 527–534. 158 indexed citations
6.
Révész, Láśzló, et al.. (1989). Variation of vascular density within and between tumors of the uterine cervix and its predictive value for radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 16(5). 1161–1163. 37 indexed citations
7.
Ujházy, Eduard, Dagmar Zeljenková, R. Nosáľ, et al.. (1989). [Teratologic and cytogenetic study of the local anesthetic, pentacaine, in rabbits].. PubMed. 38(3). 278–84. 1 indexed citations
8.
Siracká, E, et al.. (1988). Vascular density in carcinoma of the uterine cervix and its predictive value for radiotherapy. International Journal of Cancer. 41(6). 819–822. 25 indexed citations
9.
Ujházy, Eduard, Ivan Chalupa, M Blaŝko, et al.. (1988). Genotoxicological study of the local anaesthetic pentacaine in vitro micronucleus test.. PubMed. 43(8). 560–560. 2 indexed citations
10.
Ujházy, Eduard, R. Nosáľ, Dagmar Zeljenková, et al.. (1988). Teratological and cytogenetical evaluation of two antihistamines (pipethiadene and pizotifen maleate) in mice. Inflammation Research. 23(3-4). 376–378. 1 indexed citations
11.
Chalupa, Ivan, M Blaŝko, J Siracký, et al.. (1987). [The micronucleus test of the local anesthetic pentacaine on human fibroblastoid cells in vitro].. PubMed. 88(4). 396–401. 1 indexed citations
12.
Siracký, J, S. Sparrow, & Margaret T. Jones. (1984). Changes in distribution of the phases of mitosis in human tumor xenografts following drug treatment.. PubMed. 31(5). 539–44. 1 indexed citations
13.
Siracký, J, et al.. (1982). Human melanoma cell lines: morphology, growth, and alpha-mannosidase characteristics.. PubMed. 29(6). 661–8. 13 indexed citations
14.
Schreiner, Pamela J. & J Siracký. (1978). Estrogenic effect in vaginal smears in cancer of the uterine cervix.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 25(5). 637–9. 4 indexed citations
15.
Siracký, J, Pamela J. Schreiner, E Siracká, & J Matośka. (1978). Cell proliferation kinetics and nuclear morphology in endometrial cancer under progesteron treatment.. PubMed. 25(5). 535–9. 2 indexed citations
16.
Siracký, J, et al.. (1977). Cell proliferation kinetics in gynecologic cancer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 24(3). 327–32. 4 indexed citations
17.
Matośka, J & J Siracký. (1974). Histology and ultrastructure of human breast cancer in organ culture.. PubMed. 21(6). 685–96. 1 indexed citations
18.
Siracký, J, et al.. (1970). Risks and complications in surgical treatment of uterine cervix cancer stages I and II with preoperative radiotherapy and obligatory lymphadenectomy.. PubMed. 17(1). 69–77. 1 indexed citations
19.
Siracký, J. (1969). Ploidy studies in ovarian cancer during cytostatic treatment.. PubMed. 16(4). 427–33. 2 indexed citations
20.
Siracký, J. (1968). Sex chromatin in cancer of the uterine cervix.. PubMed. 11(6). 486–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026